Therapeutic agent for cerebral infarction

Details for Australian Patent Application No. 2008255885 (hide)

Owner Mitsubishi Tanabe Pharma Corporation

Inventors Ando, Naoko; Nakagawa, Haruto

Agent Griffith Hack

Pub. Number AU-A-2008255885

PCT Pub. Number WO2008/146753

Priority 2007-137504 24.05.07 JP

Filing date 23 May 2008

Wipo publication date 4 December 2008

International Classifications

C07D 401/12 (2006.01) Heterocyclic compounds containing two or more hetero rings

A61K 31/506 (2006.01) - not condensed and containing further heterocyclic rings

A61P 9/10 (2006.01) Drugs for disorders of the cardiovascular system

C07D 403/04 (2006.01) Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group

C07D 487/18 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups

Event Publications

28 January 2010 PCT application entered the National Phase

  PCT publication WO2008/146753 Priority application(s): WO2008/146753

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008255896-Novel lactic acid bacterium strain, fermented food/beverage, and method for production of fermented food/beverage

2008255877-Novel lysophosphatidate acyltransferase gene